Medicare is Changing in 2027. We’re Here to Help.
Your prescription drug costs could be impacted next year because of Medicare Part D changes. For patients taking specialty medications, understanding these updates is an important part of managing your out-of-pocket expenses.
The annual out-of-pocket threshold for Medicare Part D is increasing from $2,100 in 2026 to $2,400 in 2027.
Are you worried that these changes to your Medicare Part D coverage could increase your out-of-pocket costs?
Give us a call. Our dedicated team of OncoAdvocates can help source and connect you with available financial assistance resources, if you qualify.
In 2026, 60% of our Medicare Part D Patients Paid $0 Out-of-Pocket!
You Can Choose Your Specialty Pharmacy
When you look at the back of your prescription card, there will most likely be a specific pharmacy listed, and that can be confusing. As a Medicare Part D enrollee, you can choose the specialty pharmacy that provides the care, expertise, and support you need, regardless of the pharmacy that is on the back of your card.1 Talk to your doctor about sending your prescription to Onco360.
Why Choose Onco360?
We’re committed to exceptional patient care with a satisfaction score of 98* (out of 100).
We will act as your advocate with your doctor, insurance company, and other members of your care team.
Timing is crucial when it comes to your treatment. Our goal, without prior authorization or funding issues, is to have your medication delivered within 3-4 days.
Our OncoAdvocate® Team explores third-party funding options for eligible patients.
We make sure you understand your medications, their dosage, and any potential side effects. If you have any questions, our clinicians are on call 24/7.Choose a team of oncology experts who dedicate themselves to compassionate patient care.
If you would like more information for the Medicare changes in 2027, please visit:
If you are a provider and would like to refer to Onco360, visit
150.8.1 – Any Willing Pharmacy Requirement. https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/R1PDB.pdf
*Third party survey data provided by MMIT for Q3 2025. MMITnetwork.com